Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 31, 2021
TCR2 Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for an existing 85,000 square foot cell therapy manufacturing facility in Rockville, Maryland.
read more
Monday, November 16, 2020
TCR2 Therapeutics has established a manufacturing partnership with ElevateBio, to leverage the technical capabilities at ElevateBio BaseCamp, a cell and gene therapy manufacturing facility based in Waltham, MA.
read more
Wednesday, February 19, 2020
TCP Reliable has undergone a corporate rebranding and is now officially Integreon Global.
read more
Monday, November 06, 2023
TC BioPharm, a clinical-stage biotechnology company focused on developing allogeneic gamma-delta T cell therapies for cancer, has chosen Fortrea as its Contract Research Organization (CRO) for conducting global trials, including ACHIEVE and ACHIEVE2,...
read more
Thursday, November 05, 2020
Taysha Gene Therapies and Catalent announced a partnership to support the development and manufacturing of Taysha’s gene therapies at Catalent’s Maryland-based gene therapy facilities.
read more
Tuesday, January 14, 2020
Tauriga Sciences announced plans to commence development of a pharmaceutical grade version of Tauri-Gum.
read more
Taros Chemicals, a German small molecule contract research organization, and Welab Barcelona, Spain's largest drug discovery and development center, announced a strategic partnership to provide clients with integrated drug discovery and development ...
read more
Monday, February 24, 2020
Taro is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level.
read more
Targos GmbH, a leader in clinical biomarker services, and WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced a strategic ...
read more
Target will sell its pharmacy and clinic businesses to CVS Health in the latest twist behind a push from big retailers to become all things to all customers.
read more
Friday, November 06, 2015
TapImmune, a clinical-stage immune-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today that it has relocated its ...
read more
Tanner Pharma has announced the signing of a distribution agreement with Nephcentric, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.
read more
Tanner Pharma Group has announced the signing of a distribution agreement with Partner Therapeutics, (PTx), an integrated biopharmaceutical company.
read more
Wednesday, December 02, 2015
Tanner Pharma Group has announced the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015.
read more
Wednesday, April 23, 2025
Tanner Pharma Group has announced the opening of its new US operations facility in Charlotte, NC. This purpose-built, 22,000+ square foot facility represents a significant investment in enhancing the company’s secondary packaging, labeling, storage ...
read more